Prognostic potency of plasma LRG1 measurement at multiple time points in acute ischemic stroke patients

Juxian Gu,Chao Liu,Yan Yao
DOI: https://doi.org/10.2217/bmm-2023-0545
2024-03-06
Biomarkers in Medicine
Abstract:Objective: This study aimed to investigate the prognostic potency of LRG1 in acute ischemic stroke (AIS) patients. Methods: Plasma LRG1 levels were detected at admission and on days 3, 7 and 30 in 150 AIS patients. Results: LRG1 positively correlated with total cholesterol (p = 0.016), triglycerides (p = 0.046), C-reactive protein (p < 0.001), TNF-α (p = 0.001) and IL-6 (p = 0.004). After admission, LRG1 showed a decreasing trend (p < 0.001). Interestingly, LRG1 levels at admission (p = 0.014), day 3 (p = 0.027), day 7 (p = 0.008) and day 30 (p = 0.002) were higher in patients with modified Rankin scale score ≥2 versus those with scores <2. The LRG1 levels at day 7 (p = 0.032) and day 30 (p = 0.023) were higher in patients with recurrence versus no recurrence. Conclusion: LRG1 correlates with blood lipids, inflammation and short-term prognosis of AIS. Plasma LRG1 level is higher, and correlates with blood lipids, inflammation and short-term prognosis reflected by modified Rankin scale in acute ischemic stroke patients.
medicine, research & experimental
What problem does this paper attempt to address?